Taylor Andrew Lawrence bought OBIO
August 25, 2025 · Form 4 insider transaction
Taylor Andrew Lawrence bought 2,000 shares of Orchestra BioMed Holdings, Inc. at $2.55 per share, a transaction worth $5.1K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,000
Price
$2.55
Total value
$5.1K
InsiderTaylor Andrew Lawrence
Role—
SecurityCommon Stock, par value $0.0001 per share
Transaction codeP: Open-market purchase
Transaction dateAugust 25, 2025
Filing dateAugust 25, 2025
Shares owned after482,788
OwnershipDirect
10b5-1 planNo
AmendedNo